[Federal Register Volume 62, Number 14 (Wednesday, January 22, 1997)]
[Notices]
[Page 3298]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-1533]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute: Opportunity for a Cooperative Research
and Development Agreement (CRADA) for Partnering, Informatics and
Technology Development
AGENCY: National Cancer Institute, National Institutes of Health, PHS,
DHHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (DHHS) seeks a
company that can collaboratively pursue development of an expert,
information based system of technology development and transfer. In
particular, the Office of Technology Development (``OTD''), National
Cancer Institute seeks to co-develop a system for modeling current OTD
processes. The system will be tested using both the selected
collaborator's processes and outcomes and real-time OTD experiences.
ADDRESSES: Questions about this opportunity may be addressed to William
Cotreau, J.D., or Jeremy A. Cubert, M.S., J.D., Office of Technology
Development, NCI, 6120 Executive Blvd., MSC 7182, Bethesda, MD 20892-
7182, Phone: (301) 496-0477, Facsimile: (301) 402-2117. from whom
further information may be obtained.
DATES: In view of the important priority of developing a technology
informatics system, interested parties should notify this office in
writing no later than March 10, 1997. Respondents will then be provided
an additional 30 days for the filing of formal proposals.
SUPPLEMENTARY INFORMATION: ``Cooperative Research and Development
Agreement'' or ``CRADA'' means the anticipated joint agreement to be
entered into by NCI pursuant to the Federal Technology Transfer Act of
1986 and amendments (including 104 P.L. 133) and Executive Order 12591
of October 10, 1987 to collaborate on the specific research project
described below.
The Office of Technology Development (OTD) serves as the Institute
focal point for the implementation of the Federal Technology Transfer
Act of 1986. The OTD provides advice, guidance and assistance to
Institute staff on such things as: the development and management of
intellectual property; registration and management of patents; terms
and negotiation of licensing and research and development agreements;
management and administration of royalties; transfer of research
material; interpretation of laws, policies, rules and regulations
especially related to the implementation of the Federal Technology
Transfer Act; and other related matters.
The Government is seeking a partner with which, in accordance with
the requirements of the regulations governing the transfer of
technology in which the Government has taken an active role in
developing (37 CFR 404.8), can co-develop a system for modeling
technology development processes using information technologies. The
National Cancer Institute will provide access to its knowledge and
skill base, information regarding current processes and a test bed of
technologies not subject to confidentiality obligations. The selected
Collaborator will provide expertise in Technology Development, current
processes and market awareness.
The expected duration of the CRADA will be two (2) to five (5)
years.
The role of the National Cancer Institute, includes the following:
(1) demonstrate current technology development processes related to
transactional research agreements.
(2) proof model/equations for logical structure.
(3) provide/input historical NCI-OTD data that are not subject to
any confidentiality obligation(s) or where necessary ensure appropriate
provisions of confidentiality are applied.
(4) input collaborator historical data.
(5) review model for logical structure.
(6) provide current examples that are not subject to
confidentiality obligation(s) or where necessary ensure appropriate
provisions of confidentiality are applied in order to further test
model.
The role of the collaborator company, includes the following:
(1) program model of NCI current processes related to transactional
research agreements.
(2) provide input and feedback regarding NCI processes related to
transactional research agreements.
(3) amend model based on feedback from NCI and Collaborator.
(4) provide sufficient information about Collaborator technology
development processes to elucidate and improve model.
(5) revise model as necessary.
(6) jointly test model using current NCI technology that is not
subject to confidentiality obligation(s) as examples or where necessary
ensure appropriate provisions of confidentiality are applied.
(7) develop commercial version of technology development
information system.
(8) provide resources as necessary.
Dated: January 8, 1997.
Thomas D. Mays,
Director, Office of Technology Development, OIM, NCI.
[FR Doc. 97-1533 Filed 1-21-97; 8:45 am]
BILLING CODE 4140-10-M
